Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Short-Term Debt repayments (2021 - 2022)

Updated

Oncotelic Therapeutics' Short-Term Debt repayments came in at $41,000 for FY2024, up 17.1% from $35,000 in FY2023.

Analysis

Oncotelic Therapeutics (OTLC) Short-Term Debt repayments (2021 - 2022) Analysis & Trends

Going back to FY2020, Oncotelic Therapeutics' Short-Term Debt repayments data covers 5 years.

  • Short-Term Debt repayments carries a four-year compound annual growth rate of -4.8% (FY2020 to FY2024).
  • The five-year range for annual Short-Term Debt repayments is $35,000 (FY2023) to $95,000 (FY2021).
  • Per Business Quant, earlier years put Short-Term Debt repayments at $35,000 in FY2023 (-53.3%), $75,000 in FY2022 (-21.1%), $95,000 in FY2021 (+90.0%) and $50,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 6.45 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 15,000.00
Mar 31, 2022 60,000.00
Dec 31, 2021 20,000.00
Mar 31, 2021 75,000.00
API Access

Oncotelic Therapeutics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=OTLC&period=max&api_key=YOUR_API_KEY